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Abstract. Persistent ulcers in patients with diabetic foot syndrome in 85% of cases lead to 
amputation because of secondary infection and growing gangrene that significantly worsen the 
prognosis. In the course of our study, the data were obtained on the role of the staphylococcus, 
Pseudomonas aeruginosa infections, Enterobacteriaceae isolates, and, in a small percentage of 
cases, Candida fungus in diabetic foot syndrome. It was shown that in case of incomplete 
eradication of the pathogen the structure of pathogens and its sensitivity to antibiotics undergo 
changes. In this case, methicillin-resistant staphylococci and Pseudomonas aeruginosa are 
detected. In this paper we discuss the approaches to the choice of antibiotic therapy, subject to the 
sensitivity of these microorganisms to antibiotic therapy in the surgical department of St. Joseph 
Belgorod Regional Clinical Hospital. The obtained data state that III-IV generation pseudomonas 
cephalosporins and fluoroquinolones can be used for empirical therapy. And, in case of 
staphylococcal infections, - vancomycin. 
Keywords: diabetic foot syndrome, infection, antibiotics, antibiotic resistance. 
 
Diabetes mellitus is one of the most common high-
cost chronic diseases and the most acute medical and 
social problem. Over the past decade, the world number 
of patients with diabetes mellitus (DM) has increased 
more than 2 times, and reached 387 million people by 
the end of 2014. According to the prognosis of the 
International Diabetes Federation, nearly 592 million 
people will suffer from diabetes by 2035 [1]. 
One of the late complications of diabetes mellitus 
is a diabetic foot syndrome, which includes a set of 
pathological changes on the foot and the lower 
extremities characterized by the development of venous 
ulcers, osteo-articular lesions and purulo-necrotic 
processes in patients with DM on the background of 
neuropathy and angiopathy. This requires optimization 
of complex pharmacotherapy [2-10]. 
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Persistent ulcers in 85% of cases lead to 
amputation because of secondary infection and 
growing gangrene, which dictates the need for 
epidemiological studies for identification of patients 
with diabetic foot syndrome, determination of both 
the structure of isolated micro-organisms and their 
sensitivity. 
Objectives of the study: 
1. To study the structure of pathogens and their 
sensitivity to antibiotics in patients with diabetic foot 
syndrome undergoing treatment in the surgical 
department No.2 of St. Joseph Belgorod Regional 
Clinical Hospital in 2009-2013. 
2. To study the dynamics of changing structure 
of pathogens and their sensitivity to antibiotics under 
incomplete eradication of the pathogen and repeated 
bacteriological study in patients with diabetic foot 
syndrome undergoing treatment in the surgical 
department No.2 of St. Joseph Belgorod Regional 
Clinical Hospital in 2009-2013. 
3. To determine the antibacterial 
chemotherapeutic agents for initial and etiological 
antibiotic therapy of foot infections in diabetic 
patients in a surgical department of St. Joseph 
Belgorod Regional Clinical Hospital. 
Materials and methods: 
During 2009-2013, there were 109 patients with 
diabetic foot syndrome treated in the department of 
purulent surgery of RCH, 61.2% of them were men 
and 38.8% - women. The average age of patients was 
58.9 ± 6.8 years old, the average length of inpatient 
stay in hospital – 28.3 ± 4.3 bed-days.  
93.7% of treated patients suffer from type II 
diabetes mellitus, the average duration of diabetes 
was 10.8 ± 4.7 years. 93.7% of patients were in a 
decompensation phase of DM, and 6.3% of patients – 
in a phase of subcompensation.  
The diagnosis of diabetic foot syndrome and its 
complications was verified based on a comprehensive 
survey including data from clinical and laboratory 
researches, duplex scanning of arteries of the lower 
extremities, transcutaneous oximetry, and 
bacteriological tests of necrotic tissue. For 
determination of clinical forms of diabetic foot 
syndrome the classification proposed by I.I. Dedov 
and M.V. Shestakova, 2015, was used [1]. 
According to the type of course, we revealed 
neuropathic, ischemic and neuro ischemic variants of 
the diabetic foot syndrome. The most common was 
neuropathic course of diabetic foot syndrome – 60% 
of patients, mixed neuroischemic – 24.2% of patients, 
and ischemic – in 15.8% of patients. 
Material for bacteriological examination was 
sampled on admission of the patient to the 
department for treatment, re-sampling of 
bacteriological discharge - on day 7-10 of inpatient 
treatment under incomplete eradication of the 
pathogen. The identification of microorganism strains 
obtained from the wounds of patients with diabetic 
foot syndrome being treated in the department of 
purulent surgery of Saint Joseph Belgorod RCH in 
2009-2013. The sensitivity of microorganisms was 
determined by disk diffusion. Interpretation of the 
results was performed according to the CLSI (2012) 
and EUCAST criteria. The calculations were carried 
out with the “Statistica 10.0” applied statistical 
software package.  
Results and discussion. 
During the period of 2009-2013 total 164 strains of 
necrotic discharge were detected in patients with 
diabetic foot syndrome (Table 1). Upon analysis of 140 
strains (85.4%), isolated from necrotic material at 
admission of patients to hospital for treatment it was 
established that the necrotic lesions on patients’ foot 
have predominantly gram-positive microorganisms – 
62.2% of cases, gram-negative organisms – 29.3% of 
cases, and candida fungi – 8.5% of cases.  
It was found that the most frequently isolated 
Gram-positive microorganisms are the genus 
staphylococci: S. aureus (27.1%), and coagulase-
negative staphylococci – S. haemolyticus,  
S. epidermidis (27.9%). Gram-negative pathogens were 
mainly represented by P. aeruginosa (12.8%), plus 
microorganisms of family Enterobacteriacae, E. coli 
(6.1%), Proteus spp. (6.7%), and C. diversus (2.4%) - 
Enterobacteriacae isolates: E. coli (6.1%), Proteus spp. 
(6.7%), and C. diversus (2.4%).  In 2 cases (1.2%)  
A. baumannii was isolated, which is consistent with 
data from other researchers [11, 12].  
In the case when after 7-10 days of empirical 
antibiotic therapy there remained a purulo-necrotic 
discharge from foot wound, the patient had to 
undergo repeated bacteriological examination of 
wound. Repeated sampling for bacteriological 
examination isolated 24 strains (14.6%). The findings 
showed the prevalence of gram-positive 
microorganisms: Staphylococcus aureus – in 8 cases 
(33.3%), and coagulase-negative staphylococci – in 7 
cases (29.2%). Gram-negative bacteria P. aeruginosa 
presented in 4 cases (20.8%). 1 strain of P. mirabilis 
(4,2%) was isolated. Candida fungi were inoculated 
in 3 cases (12.5%). 
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Table 1 
Frequency of isolated bacterial pathogens isolated from patients with diabetic  
foot syndrome in 2009-2013* 
 
Pathogens  
Number of isolated strains 
2009 2010 2011 2012 2013 Total 
Citrobacter diversus 1  2 1  4 
Acinetobacter spp.    1 1 2 
Escherichia coli 2 3 3 1 1 10 
Proteus spp. 2 2 1 3/1* 2 10/1* 
Pseudomonas aeruginoza 2 2 4/2* 5/2* 4/1* 17/5* 
Staphylococcus aureus 6/1* 7 13/3* 7/3* 5/1* 38/8* 
Staphylococcus spp. 5/1* 9 12/1* 8/3* 5/2* 39/7* 
Enterococcus spp. 1 2 3 2 2 10 
Candida ssp. 2/1*  2/2* 3 3 10/3* 
Total       140/24* 
 
*Note: Note: The numerator indicates the number of strains isolated at the first sampling of material for bacteriological 
study (on hospital admission). The denominator indicates the number of strains isolated at the repeated sampling of purulent 
necrotic material.  
 
 
The analysis of antibiotic susceptibility of gram-
positive strains recorded increase of resistance to 
oxacillin in isolated strains of S. aureus and 
coagulase-negative staphylococci during 2009-2013. 
Figure 1 shows the increase in the number of 
methicillin-resistant strains of Staphylococcus aureus 
from 20% of cases in 2009 to 50% of cases in 2013, 
that is less than the level of resistance revealed by 
domestic authors in the period until 2011 [11]. The 
same trend was observed among strains of coagulase-
negative staphylococci. In 2009-2011 up to 25% of 
methicillin-resistant strains were isolated, in 2013 – 
up to 66.6% of resistant strains.  
Repeated bacteriological examination revealed a 
significantly higher level of resistance to oxacillin in  
S. aureus and coagulase-negative staphylococci than the 
original, ranging from 66.6% of the cases in 2011-2012 
up to 100% in 2009 and 2013. All isolated strains of 
Staphylococcus aureus and coagulase-negative 
staphylococci in patients with diabetic foot syndrome 
had sensitivity to vancomycin registered. According to 
foreign authors, the level of S. aureus resistance to 
oxacillin ranged from 0% of resistant strains isolated 
from patients undergoing treatment of diabetic foot 
syndrome in the surgical department of Ouagadougou 
hospital (Burkina Faso) up to 100% resistance in strains 
isolated from patients, undergoing treatment at the 
central hospital in Mexico City [13, 14]. 
 
 
Figure 1. Percentage of isolated methicillin resistant strains of staphylococcus in patients with diabetic  
foot syndrome on admission in 2009-2013. 
 
 
Enterococcus spp. was identified in 7.1% of the 
total number of strains isolated from the purulo-
necrotic discharge of foot injury taken from patients 
undergoing treatment in the surgical department No.2 
of St. Joseph Belgorod Regional Clinical Hospital, 
which is a bit less than the level obtained by US 
researchers Lipsky B.A. et al., 2012 [14], but exceeds 
the number of isolated strains according to data by 
Privolneva V.V., 2011 [11]. The isolated 
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microorganisms in 60.5% of cases were resistant to ampicillin at a detectable sensitivity to vancomycin. 
 
 
 
Figure 2. Percentage of isolated methicillin resistant strains of staphylococcus in patients with diabetic foot syndrome on 
repeated bacteriological examination in 2009-2013. 
 
 
Studying the Pseudomonas aeruginosa 
sensitivity to antibiotics an increase in resistance 
level to β-lactams was registered (Table 2). Thus, 
the resistance to cefepime reduced from 100% in 
2009-2011 up to 33.3-66.6% in 2012-2013, at the 
same time there revealed a low sensitivity to 
ceftazidime, which was 50% in 2009, and 33.3% in  
2011-2013. All isolated strains of P. aeruginosa 
showed sensitivity to meropenem and imipenem, 
except for one strain isolated in 2012, resistant to 
meropenem.  
We revealed a low sensitivity of Pseudomonas 
aeruginosa to amikacin and gentamicin: from 0% 
of strains isolated in 2010-2011 up to 50% of 
strains isolated in 2009 and 2012-2013 were 
susceptible to amikacin. Sensitivity to gentamicin 
varied from 33.3% to 66.6% at the preserved 
sensitivity to netilmicin, which ranged from 66.6% 
up to 100%. We recorded a low level of sensitivity 
to fluoroquinolones: P. aeruginosa sensitivity to 
ciprofloxacin ranged from 50% to 66.6%, with the 
exception of strains isolated in 2011, which 
showed 100% sensitivity. We revealed a reduction 
in sensitivity to levofloxacin from 100% in  
2009-2010 up to 50-66.6% in 2011-2013. In 
comparison with the data by Privolnev V.A., 2011, 
there is an increase in Pseudomonas aeruginosa 
resistance to cephalosporins, fluoroquinolones and 
aminoglycosides, in contrast to, in particular, 
netilmicin and less amikacin and gentamicin 
revealed in the studied period [11].  
Repeated bacteriological examination revealed 
strains of Pseudomonas aeruginosa not subjected to 
a complete eradication and having showed the 
presence of a reduced sensitivity to cephalosporins, 
ranging from 0% to 100% at the preserved high 
sensitivity to imipenem – in 100% of cases. 
Sensitivity to meropenem was found in 50% of P. 
aeruginosa strains, and variative sensitivity to 
gentamicin and amikacin was recorded. 
In 2010-2011 the amikacin-resistant strains 
were revealed. In 2009 and 2012-2013 up to 50% 
of strains staying susceptible to amikacin with 
continuously reducing sensitivity to 
fluoroquinolones, which was 100% in 2011, 50% 
in 2012, 100% for ciprofloxacin and 0% for 
levofloxacin in 2013. These high variations in 
sensitivity values are, probably, due to a small 
number of isolated strains and identify a trend of 
the developing resistance. The lack of absolute 
cross-resistance to meropenem and imipenem may 
be due to the peculiarities of the formation of 
resistance in P. aeruginosa. 
Identification of resistant strains of  
P. aeruginosa under incomplete eradication is 
consistent with Chinese researchers, who showed 
the relationship between multi-resistant microflora 
isolated in patients with diabetic foot syndrome, 
and a higher incidence of amputation in 33.3% of 
cases as compared with 8.7% of amputations in 
case of strains with no signs of multi-resistance 
[17]. 
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Table 2 
Susceptibility to P. aeruginosa antibiotics isolated from patients with diabetic foot syndrome in 2009-2013 
 
Antibiotics 
Number of susceptible strains, % 
2009
 
n=2 
2010
 
n=2 
2011
 
n=3 
2011
 
n=1* 
2012
 
n=3 
2012
 
n=2* 
2013
 
n=3 
2013
 
n=1* 
Ceftazidime 50 0 33.3 0 33.3 0 33.3 100 
Cefepime 100 100 66.6 100 33.3 50 66.6 0 
Meropenem 50 100 100 100 66.6 50 100 100 
Imipenem 100 100 100 100 100 100 100 100 
Ciprofloxacin 50 50 100 100 66.6 50 66.6 0 
Levofloxacin 100 100 66.6 0 66.6 50 33.3 0 
Amikacin  50 0 0 0  100 50 33.3 100 
Netilmicin  100 100 66.6 100 100  100 66.6 100 
Gentamicin  50 100 66.6 100 66.6 50 33.3  0 
Note: n – the number of isolated strains of P. aeruginosa, * – the number of strains isolated at the repeated sampling of 
purulent necrotic material.  
 
The isolated strains of A. baumannii (1.4%) had 
a high level of resistance to different groups of 
antibacterial drugs. The isolated strains are resistant 
to penicillins, cephalosporins, fluoroquinolones, 
aminoglycosides. In 100% of cases, the 
microorganisms are sensitive only to the 
carbapenems. The researches of Belgorod Regional 
Clinical Hospital revealed a higher level of resistance 
of A. baumannii as compared with the data of other 
researchers [18, 19]. 
Isolation of non-fermenting bacteria and 
methicillin-resistant Staphylococcus both during 
admission and during the re-sampling of material for 
bacteriological study is, probably, due to secondary 
nosocomial infection, which is associated with 
admission of patients after both outpatient and 
inpatient treatment.  Identification of E. coli and 
other enterobacteria, perhaps, may indicate infection 
contamination of the wound under diabetic foot 
syndrome out of hospital.   
The results of the study showed that all isolated 
strains of Enterobacteriacae were susceptible on 
admission to meropenem, imipenem/cilastatin, 
cephalosporins, which is consistent with the data of 
domestic researchers [20].  
Low activity was observed in gentamicin, 
netilmicin to Enterobacteriaceae strains isolated in 
2009-2011. (33.3-66.6%) at preserved sensitivity to 
amikacin – 100% sensitivity of the isolated strains 
among E. coli was revealed.  
In comparison with the data of other authors, a 
high sensitivity to amikacin, netilmicin was revealed 
in strains of P. mirabilis. A reduced sensitivity of  
P. mirabilis strains to gentamicin was revealed: 
strains isolated in 2009-2010 showed resistance in 
100% of cases, while in 2011-2013 – only up to 50%.  
High sensitivity of Enterobacteriaceae to 
fluoroquinolones was revealed throughout the entire 
period of study. Sensitivity to ciprofloxacin and 
levofloxacin was 100%, which is consistent with the 
data of other authors [11]. 
P. mirabilis strain isolated during the repeated 
bacteriological examination in 2012 showed its 
resistance to II-IV generation cephalosporins, 
amikacin, fluoroquinolones on the background of the 
preserved sensitivity to carbapenems, netilmicin. 
Summary: The main pathogens in case of foot 
infections on the background of diabetes mellitus are 
S. aureus, S. epidermidis, P. aeruginosa,  Proteus 
spp., E.coli. 
We have shown an increase in methicillin-
resistant strains of S. aureus, S. epidermidis from 
20% - 25% in 2009 up to 50% - 66.6% in 2013. 
We revealed an increase in resistance of  
P. aeruginosa to fluoroquinolones and the emergence 
of strains resistant to carbapenems. 
Analysis of bacteriological results showed that 
there is a change in structure of microview pathogens 
in diabetic foot under repeated bacteriological 
examinations. Mostly, the methicillin-resistant strains 
of S. aureus, S. epidermidis, P. aeruginosa with 
reduced susceptibility to III-IV generation 
cephalosporins, aminoglycosides, fluoroquinolones 
with different resistance variations are identified. 
There has been an increase in the number of 
strains of Candida spp. starting from 8.5% of cases at 
the initial sampling of wound discharge up to 12.5% 
of cases under repeated bacteriological examination. 
Drugs for empirical therapy are III-IV 
generation pseudomonas cephalosporins  
and fluoroquinolones. In case of S. aureus infections 
– vancomycin. Perhaps, the use of aminoglycosides 
after confirming the sensitivity of pathogens thereto 
in bacteriological examination. The most active 
agents in case of gram-negative flora are 
carbapenems, which must be used as a reserve 
antibiotic therapy after specification of the 
pathogenic agent.  
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